Patent delisted for Acorda drug AMPYRA

Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…

The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog